PIGT

GPI-anchor transamidase component PIGT · Q969N2 · PIGT on Sugi Atlas →

0 patent compounds predicted against PIGT, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PIGT by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Influence of the MDR1 Genotype on Blood Levels of Indinavir and Saquinavir in Healthy Volunteers PHASE4COMPLETED
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer PHASE1/PHASE2COMPLETED
Vaccine Treatment for Surgically Resected Pancreatic Cancer PHASE1/PHASE2COMPLETED
Ambroxol as a Treatment for Parkinson's Disease Dementia PHASE2UNKNOWN
OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease PHASE2COMPLETED
High-Dose Ambroxol in GBA1-Related Parkinson PHASE1/PHASE2UNKNOWN
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD PHASE2ACTIVE_NOT_RECRUITING
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) nanCOMPLETED
Transfer of GPI-Linked Proteins to Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria nanCOMPLETED
A Real-world, Multi-center, Prospective, Observational Study for PNH in China nanCOMPLETED
Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer nanNOT_YET_RECRUITING
Impaired Secretory IgA and Mucosal Immunity in Cystic Fibrosis nanUNKNOWN
Anti-αIIbβ3 Immunization in Glanzmann Thrombasthenia: Prevalence and Associated Risk Factors: Thrombasthenia Anti-αIIbβ3 Antibodies Study (TAAS) nanCOMPLETED
Human Requirements for the Nutrient Choline nanCOMPLETED
ANXA5 M2 Haplotyping in IVF Patients and Embryos nanACTIVE_NOT_RECRUITING
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects nanUNKNOWN
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) nanWITHDRAWN
Evaluation of Genetic-molecular Causes of Out-of-Hospital Cardiac Arrest: From Patients to Families nanRECRUITING
Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY Disease nanRECRUITING
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) nanRECRUITING
Choline to Improve Malnutrition and Enhance Cognition nanRECRUITING
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers nanCOMPLETED
Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) nanWITHDRAWN
A Registration Study for Familial Hypercholesterolemia in Taiwan nanUNKNOWN
Gyrate Atrophy Ocular and Systemic Study nanACTIVE_NOT_RECRUITING
Optimized PGT-M Strategy for Patients With No Proband nanENROLLING_BY_INVITATION
Genetic Analysis of Gray Platelet Syndrome nanCOMPLETED
Chest Wall Deformities in Children - Epidemiological Data nanCOMPLETED
Evaluation of Botanicals for Mechanisms Related to Appetite and Fat Metabolism nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a PIGT binder may also engage these)

ProteinNameSimilarity
Q8BXQ2 1.000 Q8BXQ2 →
Q9HCN3 0.978 Q9HCN3 →
Q6NZ07 0.976 Q6NZ07 →
Q9R1Q9 0.976 Q9R1Q9 →
Q16586 0.976 Q16586 →
F1NNL1 0.976 F1NNL1 →
ATP6AP1 V-type proton ATPase subunit S1 0.975 landscape →
L7VG99 0.975 L7VG99 →
Q6YAT4 0.975 Q6YAT4 →
EMC1 ER membrane protein complex subunit 1 0.975 landscape →
Q5RAP2 0.975 Q5RAP2 →
D3Z2R5 0.974 D3Z2R5 →
Q9ESN3 0.974 Q9ESN3 →
Q09200 0.974 Q09200 →
Q8R4K8 0.974 Q8R4K8 →
NCSTN Nicastrin 0.973 landscape →
P82350 0.973 P82350 →
Q5ZJH2 0.973 Q5ZJH2 →
Q9NXL6 0.973 Q9NXL6 →
Q6P1J0 0.973 Q6P1J0 →
Q8VCM8 0.973 Q8VCM8 →
Q6AXF6 0.973 Q6AXF6 →
Q5R7K6 0.973 Q5R7K6 →
Q8C1F4 0.972 Q8C1F4 →
Q64255 0.972 Q64255 →
Q29S03 0.972 Q29S03 →
Q5XI31 0.972 Q5XI31 →
A7E2Z9 0.972 A7E2Z9 →
P0C152 0.972 P0C152 →
PIGS GPI-anchor transamidase component PIGS 0.972 landscape →